Breast Cancer Archive

The release of new guidelines on mammography never fails to renew the heated controversy over the potential benefits and harms of this procedure. The latest draft guidelines from the U.S. Preventive Services Task Force (USPSTF) are no exception. The USPSTF recommends that women begin having mammograms at age 50 and stop at age 75. (The American Cancer Society and other medical organizations recommend that women begin getting regular mammograms at age 40.) The draft recommendations say there isn’t enough evidence to recommend or discourage the use of a new technique called 3-D mammography for screening, and also say there isn’t enough evidence to recommend that women with dense breasts, who are at higher risk of breast cancer, should have an ultrasound or MRI in addition to screening mammography. Comments can be made on the USPSTF draft until 8:00 pm Easter Time today. A final version of the recommendations is expected to be released in the fall of 2015.

Although the chance of developing breast cancer increases after age 60, the likelihood of dying from it is low.

If you're like most women, you consider the possibility of learning you have breast cancer every time you have a mammogram. But breast cancer probably doesn't seem as scary as it did when you were younger, because there has been so much good news about breast cancer in the last 20 years—improvements in mammography, advances in surgery and reconstruction, and drugs that are more effective and less toxic.

Although research suggests that women over 70 with early-stage breast cancer can skip radiation treatment, nearly two-thirds of women in that age group continue to receive it, according to findings published online Dec. 2, 2014, by the journal Cancer.

Researchers from Duke University sought to determine whether evidence from a large, randomized clinical trial published in 2004 had influenced treatment for early breast cancer. That study showed that adding radiation therapy to surgery plus tamoxifen does not reduce five-year recurrence rates or prolong survival in older women with early-stage tumors.